Sunscreen Rule Will Cost Four Times What FDA Predicted, Industry Tells OMB

FDA's low-ball estimate of costs its final OTC sunscreen monograph will impose on industry - a quarter of the amount anticipated by manufacturers - relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests